Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
about
Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model.Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes MellitusAutophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic NephropathyRenin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences.Diabetic nephropathy: What does the future hold?Have we reached the limits for the treatment of diabetic nephropathy?New molecular insights in diabetic nephropathy.Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease.Angiotensin I converting enzyme inhibitory peptides obtained after in vitro hydrolysis of pea (Pisum sativum var. Bajka) globulins.Rhein lysinate protects renal function in diabetic nephropathy of KK/HlJ mice.Vitamin D therapy in diabetic kidney disease.Renoprotective effect of Zhenwu decoction against renal fibrosis by regulation of oxidative damage and energy metabolism disorder
P2860
Q26745523-BE9DF116-AD53-42C3-A62B-2BC56F70B48AQ35813371-1F1B3A3D-8DD1-4170-91EF-E6010ED469C7Q35841020-EFD579EA-EBF4-44F0-953C-C62428F38465Q35953200-D90532C3-4A46-4A95-BD02-42CFED84421EQ36329456-EC97D47D-DEF7-4EC6-BBA2-A5628BFBE180Q36441616-CAAFCEDD-5FC3-4070-9E6A-A69E55181C45Q38189884-97A57950-489C-47EE-9B05-2429F4F13ABFQ38694219-59D108F4-5054-4F7F-BDE8-DF68F6CE4B5EQ41459702-9ABC066C-7625-4FA2-B587-4CCCF18A4CBEQ42135762-3D1E5E25-6F3F-468F-AF36-520CF159EA7CQ47097264-D523F52B-591A-41A0-9043-C9261ABBD69FQ53752460-5EDF6926-EA45-467B-8DE6-D86C62A132B8Q57050372-8A5E64FC-1E4D-4813-8034-680A614382DA
P2860
Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
description
article
@en
im April 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2013
@uk
name
Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
@en
Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
@nl
type
label
Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
@en
Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
@nl
prefLabel
Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
@en
Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
@nl
P2093
P2860
P921
P356
P1476
Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
@en
P2093
Masako Furukawa
Mitsuo Tanimoto
Tomohito Gohda
Yasuhiko Tomino
P2860
P304
P356
10.1155/2013/928197
P407
P5008
P577
2013-04-24T00:00:00Z